A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

NCT07715305 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: AD-116A
DRUG: AD-1161

Sponsor

Addpharma Inc.